GWPH stock is witnessing solid gains in early session on Monday after GW Pharmaceuticals (NASDAQ:GWPH) announced that the European regulators approved the company’s CBD oil in two seizure disorders.Impressive Development
The cannabis industry has been reeling from a supply slowdown over the past few months, and many pot stocks gave up their gains. However, today, the industry received a huge boost from the European Union. In a landmark development, the relevant regulatory authority in the European Union has approved the cannabis-based medicine called Epidiolex, manufactured by GW Pharmaceuticals, as a prescription.
This is ...
Get the latest marijuana stock news, cannabis on stock news on PotStockNews